Marijuana matters: reviewing the impact of marijuana on cognition, brain structure and function, & exploring policy implications and barriers to research

The neurobiologic effects of cannabis, commonly referred to as 'marijuana' (MJ), have been studied for decades. The impact of recreational MJ use on cognition and measures of brain function and structure is outlined, and variables influencing study results are discussed, including age of t...

Full description

Saved in:
Bibliographic Details
Published in:International review of psychiatry (Abingdon, England) England), 2018-06, Vol.30 (3), p.251-267
Main Authors: Sagar, Kelly A., Gruber, Staci A.
Format: Article
Language:English
Subjects:
Best practice
Brain - diagnostic imaging
Brain - drug effects
Brain research
Brain structure
cannabis
Cognition
Cognitive Dysfunction - chemically induced
Consumers
Humans
Information needs
Legalization
Legislation, Drug
Marijuana
Marijuana Use - adverse effects
medical marijuana
Medical Marijuana - pharmacology
MRI
neuroimaging
policy
Policy making
Public Policy
Recreation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The neurobiologic effects of cannabis, commonly referred to as 'marijuana' (MJ), have been studied for decades. The impact of recreational MJ use on cognition and measures of brain function and structure is outlined, and variables influencing study results are discussed, including age of the consumer, patterns of MJ use, variations in MJ potency, and the presence of additional cannabinoids. Although evidence suggests that chronic, heavy recreational MJ use is related to cognitive decrements and neural changes, particularly when use begins in adolescence, findings from studies of recreational MJ users may not be applicable to medical marijuana (MMJ) patients given differences in demographic variables, product selection, and reasons for use. Although additional research is needed to fully understand the impact of MJ and individual cannabinoids on the brain, current findings are beginning to inform public policy, including considerations for age limits, potential limits for some cannabinoids, and guidelines for use. However, barriers continue to impede researchers' ability to conduct studies that will guide policy change and provide vital information to consumers and patients regarding best practices and safest methods for use. The need for information is critical, as legalization of MJ for medical and recreational use is increasingly widespread.
ISSN:0954-0261
1369-1627
DOI:10.1080/09540261.2018.1460334